The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
about
The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease.
P2860
The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The effect of FcγRIIA and FcγR ...... hildren with Kawasaki disease.
@en
The effect of FcγRIIA and FcγR ...... hildren with Kawasaki disease.
@nl
type
label
The effect of FcγRIIA and FcγR ...... hildren with Kawasaki disease.
@en
The effect of FcγRIIA and FcγR ...... hildren with Kawasaki disease.
@nl
prefLabel
The effect of FcγRIIA and FcγR ...... hildren with Kawasaki disease.
@en
The effect of FcγRIIA and FcγR ...... hildren with Kawasaki disease.
@nl
P2093
P2860
P356
P1433
P1476
The effect of FcγRIIA and FcγR ...... hildren with Kawasaki disease.
@en
P2093
Ho-Chang Kuo
Ling-Sai Chang
Mao-Hung Lo
Sung-Chou Li
P2860
P304
P356
10.18632/ONCOTARGET.13489
P407
P577
2016-11-21T00:00:00Z